|
rdfs:label
|
"Infliximab"@sk
"Infliximab"@de
"Infliximabe"@pt-br
"gammaglobulina"@eu
"infliksimab"@nn
"infliksimab"@sh
"infliksimab"@sl
"infliksimab"@sr
"infliksimab"@tr
"infliksimabi"@fi
"infliksymab"@pl
"infliximab"@ca
"infliximab"@cs
"infliximab"@en
"infliximab"@en-ca
"infliximab"@en-gb
"infliximab"@es
"infliximab"@fr
"infliximab"@id
"infliximab"@it
"infliximab"@nl
"infliximab"@ro
"infliximab"@sv
"infliximab"@vi
"infliximabe"@pt
"Ινφλιξιμάμπη"@el
"Инфликсимаб"@mk
"инфликсимаб"@ru
"інфліксімаб"@uk
"רמיקייד"@he
"إنفليكسيماب"@ar
"اینفیلیکسیماب"@azb
"اینفیلیکسیماب"@fa
"ଇନଫ୍ଲିକ୍ସିମାବ"@or
"インフリキシマブ"@ja
"英夫利昔單抗"@zh
"인플릭시맵"@ko
|
|
skos:altLabel
|
"Ig gamma-1 chain C region"@en
"cA2"@en
"infliximab"@fi
"infliximab"@nb
"レミケード"@ja
"英利昔單抗"@zh
|
|
schema:description
|
"TNF-α inhitibitörü biyolojik ilaç"@tr
"cheemesch Verbindung"@lb
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"composto químico"@gl
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"farmaco"@it
"fàrmac"@ca
"immunhämmande läkemedel"@sv
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"medicamento"@pt
"organisches Makromolekül, chimärer monoklonaler Antikörper, Immunsuppressivum"@de
"pharmaceutical drug"@en
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"медицинский препарат"@ru
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"କେତେକ ଅଟୋଇମ୍ମ୍ୟୁନ ରୋଗରେ ଦିଆଯାଏ ।"@or
"രാസസംയുക്തം"@ml
|
|
schema:dateModified
|
"2026-11-04T17:27:54+00:00"^^xsd:dateTime
|
|
schema:version
|
2564773306
|
|
wikibase:identifiers
|
35
|
|
wikibase:sitelinks
|
34
|
|
wikibase:statements
|
76
|
|
p:P10245
|
wd:statement/Q415264-0411e411-40f9-4e39-137c-78f6529f0450
|
|
p:P10283
|
wd:statement/Q415264-88FE0464-87EC-4150-B2FB-B06E8D9CE988
|
|
p:P11143
|
wd:statement/Q415264-4229F22B-3B56-4BC9-9F72-AF9A8127B5CC
|
|
p:P1417
|
wd:statement/Q415264-E90C876B-5234-4B14-826E-616C3F044400
|
|
p:P1552
|
wd:statement/Q415264-AB03C5BB-5C40-4D25-987E-25AD514DA4B3
|
|
p:P2062
|
wd:statement/Q415264-D12E6DF9-57C5-4ACF-92FD-AF1D5B1E8091
|
|
p:P2115
|
wd:statement/Q415264-F4851123-F57D-4B7F-9A8F-3DDA15D904B4
|
|
p:P2175
|
wd:statement/Q415264-006A9027-A120-456A-A578-E984E28F450C
|
|
wd:statement/Q415264-17F19C7D-621E-4578-9D65-D284A5FD961A
|
|
wd:statement/Q415264-1BD206A5-4DA9-4C6A-AA66-49468074C656
|
|
wd:statement/Q415264-36F5AF50-5990-4904-B8E3-4B7AAFB3C78F
|
|
wd:statement/Q415264-4BAA9765-63E1-4D52-9415-6BACD1B3EB19
|
|
wd:statement/Q415264-4CA1DB66-BCA5-46E2-AFC4-D95BB6B4F642
|
|
wd:statement/Q415264-5D618858-D745-4E28-84F9-AF115CE1F666
|
|
wd:statement/Q415264-9516D1D6-C919-45BF-97A3-8BD951C37E03
|
|
wd:statement/Q415264-BAF483E9-B88D-4F32-91B1-6DF414C0C7BC
|
|
wd:statement/Q415264-CAB77C30-5FF3-4332-85CE-E33C6ABF40FD
|
|
wd:statement/Q415264-F0CE8E1C-2D9D-43E0-B5F2-F281651C4024
|
|
wd:statement/Q415264-FD513DED-F9B3-4F3C-B5CA-7BA29723471E
|
|
p:P2275
|
wd:statement/Q415264-1d5af7e4-417b-b1e9-ede9-4bc9235d5811
|
|
wd:statement/Q415264-3373aa86-4ebe-277d-8aea-4f58065167b5
|
|
wd:statement/Q415264-43319E20-9103-4533-9680-18C2743A0E31
|
|
wd:statement/Q415264-5700816a-496d-e9ad-5743-679dc78b379b
|
|
wd:statement/Q415264-60200dfd-4cbf-1b32-8793-8f641a26621c
|
|
wd:statement/Q415264-679fbcbb-4993-d643-078c-a5d9d6943300
|
|
wd:statement/Q415264-986f1dc0-47d8-2e36-4b3f-220685a59f65
|
|
p:P231
|
wd:statement/Q415264-8347EFA3-4C75-48D6-B853-56E415F6DCE7
|
|
p:P267
|
wd:statement/Q415264-293f79e3-472e-829c-35e5-9194f3d5ac8e
|
|
p:P279
|
wd:statement/Q415264-0BFC2030-6DB9-47F6-A768-38F7A15244AD
|
|
p:P2840
|
wd:statement/Q415264-6DAC070B-543A-4CEA-83A8-8734935E96D0
|
|
p:P2868
|
wd:statement/Q415264-09D0F4A6-DDD7-47E6-860E-D65CF786AB8D
|
|
wd:statement/Q415264-411FDC09-2385-4654-8C94-030E004B4021
|
|
wd:statement/Q415264-85E1ACF6-8A9E-4AAF-8B69-0C9F9405A176
|
|
wd:statement/Q415264-ACAC1D86-B6BC-4540-888D-53BD4326F3F1
|
|
wd:statement/Q415264-DC5A53D2-FB11-449D-B558-0D4F1DF7DEBC
|
|
p:P2892
|
wd:statement/Q415264-0507C0DB-06C5-415D-89DA-C83AA42C4EF5
|
|
p:P31
|
wd:statement/Q415264-DF630E13-096A-4983-B79D-95F25AC1C51C
|
|
p:P3117
|
wd:statement/Q415264-1F0D6FF9-46A6-4FCE-83ED-67B32FAF437B
|
|
p:P3221
|
wd:statement/Q415264-4DC0658C-67F8-4BC6-B3A1-9F4638668C96
|
|
p:P3345
|
wd:statement/Q415264-457665FC-1CE2-4CCF-A03E-CC15BC7C3A34
|
|
p:P3350
|
wd:statement/Q415264-6d9dd76d-4a62-ff68-7ef9-9b1033b8222a
|
|
p:P3417
|
wd:statement/Q415264-E43A7614-970E-4DA2-9B35-D5E4AF8A4778
|
|
p:P3489
|
wd:statement/Q415264-6E29B81A-8F98-449C-9B25-0A426D24FB2F
|
|
wd:statement/Q415264-FDD5A724-0274-40ED-B669-381F87632851
|
|
p:P3493
|
wd:statement/Q415264-A8381DE3-8668-4D91-8360-C1FBDFF38E01
|
|
p:P366
|
wd:statement/Q415264-1D0E395E-6896-4E62-9465-CA7C6CF338CE
|
|
p:P373
|
wd:statement/Q415264-5913273f-4bba-6a3c-dd9d-a9c892423945
|
|
p:P3780
|
wd:statement/Q415264-5481528C-1C81-41BA-9117-220EF2875A74
|
|
wd:statement/Q415264-805B2320-AAEA-4D8A-A81D-464D874F4033
|
|
wd:statement/Q415264-83C9C27C-D7A1-42A3-AD5B-BE134E981F3C
|
|
wd:statement/Q415264-B4C97ACF-C524-42B3-9786-1ED88420BACF
|
|
p:P4235
|
wd:statement/Q415264-D5984EE7-F633-4E53-8426-A7267A8E3DB6
|
|
p:P4250
|
wd:statement/Q415264-607F8BA9-8BF5-4EAB-9B6F-0FDDB10D2C1D
|
|
p:P486
|
wd:statement/Q415264-B5ED1411-6640-4843-A866-13EC3AE713B4
|
|
p:P5019
|
wd:statement/Q415264-DD037AA7-2181-4918-8175-B9C25DCE719C
|
|
p:P5082
|
wd:statement/Q415264-200ae8e0-bbd5-4433-9a63-a06ccbae0a22
|
|
p:P592
|
wd:statement/Q415264-E77E5F84-BFFD-4F81-B627-79C36493AA7B
|
|
p:P595
|
wd:statement/Q415264-2eb35c9a-431c-2126-59e5-3bf0ab24e81e
|
|
p:P636
|
wd:statement/Q415264-f72b139f-49c0-3151-f03f-de7be54fd941
|
|
p:P6366
|
wd:statement/Q415264-D445E3B6-31CF-4870-9A98-8778A3C4565C
|
|
wd:statement/Q415264-EAF244D8-8201-46BA-8FB5-8AF1F8113B81
|
|
p:P646
|
wd:statement/Q415264-DB442FAE-4DAE-420F-BA2B-8C5F95FFCC93
|
|
p:P652
|
wd:statement/Q415264-19EBE939-CB40-4E30-A47E-06279F3A3976
|
|
p:P665
|
wd:statement/Q415264-E9193C1F-1025-4B8A-908F-72CF0A9E371C
|
|
p:P672
|
wd:statement/Q415264-34a41f00-4326-df7f-f044-5ae165fc06da
|
|
wd:statement/Q415264-36bcc7f5-4052-6944-3a83-da19921bb605
|
|
wd:statement/Q415264-4290d7ac-4943-0fcd-3acc-5dc02d7c1665
|
|
p:P715
|
wd:statement/Q415264-46D5FFCD-0D9E-4169-BC85-82715D04BB01
|
|
p:P7830
|
wd:statement/Q415264-615C4C34-A6B0-4084-850A-69D38C177EB4
|
|
p:P8026
|
wd:statement/Q415264-1C08EC72-E0D8-4988-BE8B-0BD1DF137F29
|
|
p:P8224
|
wd:statement/Q415264-9E354B7B-BBF4-4CD5-9C79-7C57599E7E1D
|
|
p:P8814
|
wd:statement/Q415264-EBFC85C8-8B6D-4081-9743-D4B6D85720E7
|
|
p:P9272
|
wd:statement/Q415264-B54DB938-A36F-467E-82AC-354932850460
|
|
p:P950
|
wd:statement/Q415264-33F93049-BF70-48C7-A528-D21990E0D861
|
|
p:P9635
|
wd:statement/Q415264-668713DC-AE80-4EF6-86C2-C100F641AB03
|
|
p:P9989
|
wd:statement/Q415264-D7CE08DB-B038-4F36-8294-58EB346111DF
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000148580>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D000069285>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201581>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2777138892>
|
|
<https://makg.org/entity/2910408542>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D02598>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D12.776.124.486.485.114.224.608>
|
|
<http://id.nlm.nih.gov/mesh/D12.776.124.790.651.114.224.537>
|
|
<http://id.nlm.nih.gov/mesh/D12.776.377.715.548.114.224.642>
|
|
p:direct-normalized/P8814
|
<http://wordnet-rdf.princeton.edu/rdf/id/03574837-n>
|
|
p:direct-normalized/P950
|
<https://datos.bne.es/resource/XX551354>
|
|
wdt:P10245
|
"a604023"
|
|
wdt:P10283
|
"C2777138892"
|
|
wdt:P11143
|
"Infliximab"
|
|
wdt:P1417
|
"topic/infliximab"
|
|
wdt:P1552
|
biopharmaceutical
|
|
wdt:P2062
|
"7850"
|
|
wdt:P2115
|
"N0000148580"
|
|
wdt:P2175
|
polyarthritis
|
|
ulcerative colitis
|
|
pyoderma gangrenosum
|
|
arthritis
|
|
spondylitis
|
|
colitis
|
|
Kawasaki disease
|
|
uveitis
|
|
Takayasu's arteritis
|
|
ankylosing spondylitis
|
|
irritable bowel syndrome
|
|
Behçet's disease
|
|
wdt:P2275
|
"infliximab"@en
"infliximab"@es
"infliximab"@fr
"infliximabum"@la
"инфликсимаб"@ru
"إينفليكسيماب"@ar
"英利昔单抗"@zh
|
|
wdt:P231
|
"170277-31-3"
|
|
wdt:P267
|
"L04AB02"
|
|
wdt:P279
|
chemical compound
|
|
wdt:P2840
|
"728729"
|
|
wdt:P2868
|
dermatologic drug
|
|
monoclonal antibody
|
|
immunologic factor
|
|
gastrointestinal agent
|
|
disease-modifying antirheumatic drug
|
|
wdt:P2892
|
"C0666743"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID9040504"
|
|
wdt:P3221
|
"subject/remicade-drug"
|
|
wdt:P3345
|
"191831"
|
|
wdt:P3350
|
"7602"
|
|
wdt:P3417
|
"Infliximab"
|
|
wdt:P3489
|
US pregnancy category B
|
|
Australian pregnancy category C
|
|
wdt:P3493
|
boxed warning
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Infliximab"
|
|
wdt:P3780
|
Flixabi
|
|
Inflectra
|
|
Remicade
|
|
Remsima
|
|
wdt:P4235
|
"infliximab"
|
|
wdt:P4250
|
3.75^^xsd:decimal
|
|
wdt:P486
|
"D000069285"
|
|
wdt:P5019
|
"infliximab"
|
|
wdt:P5082
|
"infliksimab"
|
|
wdt:P592
|
"CHEMBL1201581"
|
|
wdt:P595
|
"5004"
|
|
wdt:P636
|
intravenous infusion and defusion
|
|
wdt:P6366
|
"2777138892"
|
|
"2910408542"
|
|
wdt:P646
|
"/m/01vzrk"
|
|
wdt:P652
|
"B72HH48FLU"
|
|
wdt:P665
|
"D02598"
|
|
wdt:P672
|
"D12.776.124.486.485.114.224.608"
|
|
"D12.776.124.790.651.114.224.537"
|
|
"D12.776.377.715.548.114.224.642"
|
|
wdt:P715
|
"DB00065"
|
|
wdt:P7830
|
"Infliximab"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category A
|
|
wdt:P8224
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Infliximab%20structure2.jpg>
|
|
wdt:P8814
|
"03574837-n"
|
|
wdt:P9272
|
"55983"
|
|
wdt:P950
|
"XX551354"
|
|
wdt:P9635
|
"549"
|
|
wdt:P9989
|
"inFLIXimab"
|
